Ensoma names new CEO

By The Science Advisory Board staff writers

October 11, 2021 -- Ensoma has named Emile Nuwaysir, PhD, as its new president and CEO.

Nuwaysir is currently chair of the Alliance for Regenerative Medicine and vice chair of Invenra, an antibody platform company he co-founded in 2011. He previously served as CEO at BlueRock Therapeutics, a Bayer Pharmaceuticals subsidiary, and will continue to chair that company's board. Before his position at BlueRock, Nuwaysir was president and CEO of Cellular Dynamics International and a member of senior management at NimbleGen Systems.


Copyright © 2021 scienceboard.net
 


MemberID or email address:

Password:
Forgot your password?